Cullgen Announces Publication of Small Molecule BRAF Protein Degraders in Journal of Medicinal Chemistry
SAN DIEGO--(BUSINESS WIRE)--Cullgen Inc., a leading biotechnology company developing small molecule therapeutics based on its proprietary uSMITE™ platform of targeted...











